Hibiscus Sabdariffa Extract Effect on Neuromuscular Performance

NCT ID: NCT05653076

Last Updated: 2023-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-23

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Exercise-induced muscle damage (EIMD) is a transient problem that athletes face after performing more intense and/or prolonged exercise than they are used to. EIMD is accompanied by an increase in the production of reactive oxygen species and a decrease in the antioxidant capacity of the organism. This phenomenon decreases the performance capacity of athletes due to impaired muscle strength and range of motion. Among the strategies to reduce EIMD, the use of nutritional strategies rich in antioxidants such as polyphenols stands out. In this sense, the extract of Hibiscus sabdariffa is particularly rich in polyphenolic antioxidants, among which anthocyanins stand out. Previous studies have concluded that the administration of an extract of Hibiscus sabdariffa can prevent overtraining syndrome by reducing the levels of oxidizing agents and increasing the body's antioxidant defenses. However, despite the fact that Hibiscus sabdariffa extract has been shown to be safe for humans to ingest and have various health benefits, to our knowledge, no studies have evaluated its ability to minimize neuromuscular performance impairment that occurs after performing an intense session of strength training. Based on previous evidence, we hypothesize that supplementation with an extract of Hibiscus sabdariffa will improve neuromuscular performance after performing intense resistance exercise in young (18-35 years) and trained adults, with at least 1 year of experience training. strength. The design of this study is crossover, randomized and placebo controlled, where each individual will act as her own control. The neuromuscular performance parameters to be evaluated will be: i) explosive strength - main variable, in terms of countermovement jump height (CMJ); ii) the maximum dynamic force; and iii) the ability to change direction, all of them 24h and 72h after a high-intensity strength training session. If our hypothesis is confirmed, the results of our study would not only have an impact at a scientific level but also at a commercial level through the development of supplements and/or functional foods.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
triple-blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Microcrystalline cellulose

Group Type PLACEBO_COMPARATOR

Hibiscus sabdariffa extract

Intervention Type DIETARY_SUPPLEMENT

Daily supplementation with 520 mg of Hibiscus sabdariffa extract for 10 days.

Hibiscus sabdariffa extract

520 mg of Hibiscus sabdariffa extract

Group Type EXPERIMENTAL

Hibiscus sabdariffa extract

Intervention Type DIETARY_SUPPLEMENT

Daily supplementation with 520 mg of Hibiscus sabdariffa extract for 10 days.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hibiscus sabdariffa extract

Daily supplementation with 520 mg of Hibiscus sabdariffa extract for 10 days.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 18-35 years.
* Body mass index: 18.5-30 kg/m2
* Be able to understand the instructions, objectives, and protocol of the study.
* Trained in some force sports discipline ≥1 year prior to the study and accustomed to carrying out the exercises of the evaluation protocol.

Exclusion Criteria

* History of a major adverse cardiovascular event, renal failure, cirrhosis, eating disorder, polycystic ovarian syndrome, weight control surgery, type 2 diabetes mellitus, or HIV/AIDS.
* Any chronic pathology in which the intake of nutritional supplements is not recommended.
* Any condition that, in the investigator's judgment, impairs the ability to participate in the study or represents a personal risk to the participant.
* Use of medications that may affect the results of the study.
* Unstable body weight for 3 months prior to study start (\>4 kg weight gain or loss)
* Routine use of teas/infusions/supplements rich in polyphenols.
* Pregnancy and lactation.
* Active tobacco or illicit drug use or history of treatment for alcohol abuse.
* To be on a special diet or prescribed for other reasons (eg celiac disease).
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Granada

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Francisco Javier Osuna-Prieto

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Instituto Mixto Universitario Deporte y Salud (iMUDS)

Granada, , Spain

Site Status RECRUITING

Facultad de Ciencias del Deporte

Granada, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Francisco J Osuna-Prieto, PhD

Role: CONTACT

+34 618117577

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Francisco Javier O Osuna-Prieto, PhD.

Role: primary

+34 618117577

Francisco J O Osuna-Prieto, PhD

Role: primary

+34 618117577

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1364-N-22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Green Tea Extract and Ginger
NCT07150533 COMPLETED NA